Perspectives from Italy during the COVID-19 pandemic: nationwide survey-based focus on minimally invasive HPB surgery.

Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 101539818 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2038-3312 (Electronic) Linking ISSN: 2038131X NLM ISO Abbreviation: Updates Surg Subsets: MEDLINE

Original Publication: Milano : Springer-Verlag Italia

Coronavirus Infections* ; Minimally Invasive Surgical Procedures* ; Pandemics* ; Pneumonia, Viral*; Biliary Tract Diseases/*surgery ; Liver Diseases/*surgery ; Pancreatic Diseases/*surgery; COVID-19 ; Health Care Surveys ; Humans ; Italy

The safety of minimally invasive procedures during COVID pandemic remains hotly debated, especially in a country, like Italy, where minimally invasive techniques have progressively and pervasively entered clinical practice, in both the hepatobiliary and pancreatic community. A nationwide snapshot of the management of HPB minimally invasive surgery activity during COVID-19 pandemic is provided: a survey was developed and conducted within AICEP (Italian Association of HepatoBilioPancreatic Surgeons) with the final aim of conveying the experience, knowledge, and opinions into a unitary report enabling more efficient crisis management. Results from the survey (81 respondents) show that, in Italian hospitals, minimally invasive surgery maintains its role despite the COVID-19 pandemic, with the registered reduction of cases being proportional to the overall reduction of the HPB surgical activity. Respondents agree that the switch from minimally invasive to open technique can be considered as a valid option for cases with a high technical complexity. Several issues merit specific attention: screening for virus positivity should be universally performed; only expert surgical teams should operate on positive patients and specific technical measures to lower the biological risk of contamination during surgery must be followed. Future studies specifically designed to establish the true risks in minimally invasive surgery are suggested. Furthermore, a standard and univocal process of prioritization of patients from Regional Healthcare Systems is advisable.

J Natl Compr Canc Netw. 2020 Mar 20;:1-4. (PMID: 32197238)
Ann Surg. 2020 Jul;272(1):e27-e29. (PMID: 32221117)
J Clin Med. 2020 Mar 30;9(4):. (PMID: 32235486)
Ann Surg. 2020 Jul;272(1):e5-e6. (PMID: 32221118)
Updates Surg. 2017 Sep;69(3):271-283. (PMID: 28861759)
Br J Surg. 2020 Jun;107(7):785-787. (PMID: 32191340)
J Visc Surg. 2020 Jun;157(3S1):S7-S12. (PMID: 32249098)
Updates Surg. 2019 Mar;71(1):97-103. (PMID: 29770922)
Crit Care Resusc. 2020 Apr 01;22(2):91-94. (PMID: 32227819)
Ann Oncol. 2020 Jul;31(7):840-843. (PMID: 32243893)

Investigator: M Abu Hilal; S Andrianello; A Anselmo; F Ardito; LB Gian; F Banchini; M Barabino; A Barberis; C Bassi; G Batignani; C Battiston; A Belli; S Berti; P Bianco; A Brolese; S Brozzetti; G Butturini; F Calise; K Carabott; G Capretti; R Casadei; M Cescon; M Cesaretti; U Cillo; N Cinardi; M Colledan; A Coppola; C Cotsoglou; S Crippa; ED Bona; RD Valle; M De Angelis; L De Carlis; F Di Benedetto; P Di Sebastiano; L Dova; G Ercolani; A Esposito; ME Giuseppe; A Fabris; A Ferrero; A Frena; I Frigerio; L Gianotti; A Giuliani; F Giuliante; G Grazi; E Gringeri; G Griseri; S Gruttadauria; A Guglielmi; F Izzo; E Jovine; E Lanza; G Malleo; L Manzini; M Massani; V Mazzaferro; R Memeo; F Minni; L Morelli; G Nappo; B Nardo; F Orlando; S Partelli; A Patriti; R Patrone; A Percivale; G Piccolo; M Ravaioli; P Reggiani; M Risaliti; A Rocca; R Romagnoli; F Romano; N Russolillo; A Ruzzenente; E Saladino; R Salvia; R Santambrogio; P Tarchi; A Troci; R Troisi; L Urbani; L Veneroni; G Vennarecci; L Vigano; M Viola; F Vistoli; M Vivarelli; M Zanello; G Zanus; A Zerbi
Keywords: COVID-19; Liver; Minimally invasive; Pancreas; Pandemic

Date Created: 20200531 Date Completed: 20200706 Latest Revision: 20201218

20221213

PMC7259429

10.1007/s13304-020-00815-5

32472403